Clinical trials: Radiomic

NSCLC

Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma

• Completed
• Age: 18 years and older
• Observational study

Retrospective study in patients with therapy-naive non small cell lung carcinoma correlating presurgical F18-FDG-PET/CT imaging texture analysis data with postsurgical molecular pathology data and clinical patient outcome.

Trial name

PANU (NCT04276025)

Testing

Clinical routine F18-FDG-PET/CT, molecular pathology and clinical outcome

Volunteers

2,000 people

Sponsor

Klinikum Bayreuth GmbH